Tevogen Regains Nasdaq Minimum Market Value Compliance

Tevogen Inc. announced it has regained compliance with Nasdaq's minimum market value of publicly held shares requirement. The company received official notification from Nasdaq on September 9, 2026, confirming that it now meets the $15 million threshold under Listing Rule 5450(b)(2&3)(C). As a result, the issue is considered closed, ensuring the company's continued listing on The Nasdaq Global Market.